Literature DB >> 32079521

Modeling of the Enzyme-Substrate Complexes of Human Poly(ADP-Ribose) Polymerase 1.

D K Nilov1, S V Pushkarev2, I V Gushchina2, G A Manasaryan3, K I Kirsanov4, V K Švedas5,2.   

Abstract

Poly(ADP-ribose) polymerase 1 (PARP-1) is a key DNA repair enzyme and an important target in cancer treatment. Conventional methods of studying the reaction mechanism of PARP-1 have limitations because of the complex structure of PARP-1 substrates; however, the necessary data can be obtained by molecular modeling. In this work, a molecular dynamics model for the PARP-1 enzyme-substrate complex containing NAD+ molecule and the end of the poly(ADP-ribose) chain in the form of ADP molecule was obtained for the first time. Interactions with the active site residues have been characterized where Gly863, Lys903, Glu988 play a crucial role, and the SN1-like mechanism for the enzymatic ADP-ribosylation reaction has been proposed. Models of PARP-1 complexes with more sophisticated two-unit fragments of the growing polymer chain as well as competitive inhibitors 3-aminobenzamide and 7-methylguanine have been obtained by molecular docking.

Entities:  

Year:  2020        PMID: 32079521     DOI: 10.1134/S0006297920010095

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  2 in total

1.  Toxicological Properties of 7-Methylguanine, and Preliminary Data on its Anticancer Activity.

Authors:  Kirill Kirsanov; Timur Fetisov; Elena Antoshina; Lubov Trukhanova; Tatiana Gor'kova; Olga Vlasova; Irina Khitrovo; Ekaterina Lesovaya; Nataliya Kulbachevskaya; Tatiana Shcherbakova; Gennady Belitsky; Marianna Yakubovskaya; Vytas Švedas; Dmitry Nilov
Journal:  Front Pharmacol       Date:  2022-07-06       Impact factor: 5.988

2.  Mechanisms of Nucleosome Reorganization by PARP1.

Authors:  Natalya V Maluchenko; Dmitry K Nilov; Sergey V Pushkarev; Elena Y Kotova; Nadezhda S Gerasimova; Mikhail P Kirpichnikov; Marie-France Langelier; John M Pascal; Md Sohail Akhtar; Alexey V Feofanov; Vasily M Studitsky
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.